Interestingly, PIPP-deficient breast cancer cells exhibit decreased levels of the matrix metalloproteinase MMP2, which digests collagen type IV23, suggesting that PIPP may also regulate extracellular matrix remodeling. This evidence concerns the gene MMP2 and breast carcinoma.